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Abstract
Background: Yuzu (Citrus junos Sieb. ex Tanaka), a yellow-golden colored citrus fruit, has traditionally been used to
promote psychosomatic health in Japan. While the yuzu produces a distinctive, pleasing aroma of citrus and floral,
the efficacy of its fragrance remains unknown. The present study investigated the soothing effects of the fragrance
of yuzu essential oil from the perspective of autonomic nervous system activity, which plays a crucial role in the
integrity of the mind-body connection.
Methods: Twenty one women in their 20s participated in a single-blind randomized controlled crossover study.
Subjects were examined twice each in the follicular and late-luteal phases. Two kinds of aromatic stimulation
(yuzu and water as a control) were used. This experiment measured heart rate variability (HRV) reflecting autonomic
nervous system activity and used the Profile of Mood States (POMS) as a psychological index before and after the
aromatic stimulation.
Results: Only a 10-min inhalation of the yuzu scent significantly decreased heart rate and increased high frequency
power of HRV reflecting parasympathetic nervous system activity, regardless of menstrual phase. This significant
physiological effect continued for at least 25 min. In addition, the POMS tests revealed that inhalation of the
aromatic yuzu oil significantly decreased total mood disturbance, a global measure of affective state, together with
two POMS subscales—tension-anxiety and fatigue, as long as 35 min after the aroma stimulation, both in the
symptomatic late-luteal and non-symptomatic follicular phases.
Conclusions: The present study provides the novel information that yuzu’s aromatic effects could serve to alleviate
negative emotional stress, which, at least in part, would contribute to the improvement of parasympathetic nervous
system activity.
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Background
According to the systemic investigation of national mental
health surveys, stress-related psychological and emotional
disorders are 20 to 40% more common in women than
men in any given year [1]. As to stress management strat-
egies, women often seek safe and effective options for
their healthcare conditions. The practice of aromathera-
py—a form of complementary and alternative medici-
ne—uses volatile plant materials, known as essential oils,
to balance mind, body, and spirit and has a long history of
use in supporting women’s health and lifestyles [2, 3]. A
number of essential oils are currently in use as aroma-
therapy agents to relieve stress, anxiety, and depression.
Popular oils include lavender, rose, orange, bergamot,
lemon, sandalwood, clary sage, Roman chamomile, and
rose-scented geranium [4].
Beyond its role as an essential ingredient in food prod-
ucts and various cuisines, yuzu (Citrus junos Sieb. ex
Tanaka), a yellow-golden colored citrus fruit resembling
a small orange or tangerine, has traditionally been used
to promote mind and body health in Japan. For instance,
taking a yuzu-yu (yuzu bath), a hot bath in which whole
yuzu fruits are floated, is a winter solstice custom that
dates back to at least the early 18th century. While
enjoying the yuzu aroma, a relaxing soak relieves stress
and creates a feeling of well-being. The yuzu bath is also
said to warm the body, guard against colds, and treat
arthritis, rheumatism, and the roughness of skin [5]. The
essence of yuzu fragrance falls somewhere between
grapefruit and mandarin with subtle overtones of berga-
mot and lime, while producing a very appealing, almost
floral note [6]. Because of its distinctive pleasing fra-
grance, aromatic and/or cosmetic products of yuzu are
now commercially available as a healthcare modality.
Studies from Japanese scientific journals suggest the
healing effects of the yuzu fragrance and its potential
application to aromatherapy [7, 8]. However, an exten-
sive literature search for the present study, using the
PubMed database, revealed a paucity of empirical
human-subject research regarding the efficacy of yuzu
fragrance on the psychophysiological health for women.
The autonomic nervous system plays vital roles in dy-
namically controlling the response of the body to a range of
external and internal stimuli and ingeniously modulating
biological homeostasis in humans. Instability, or even a
slight disorder of the system, therefore, could induce
broadly ranged psychophysiological phenomena and, ultim-
ately, far-reaching adverse effects on health. An electrocar-
diogram (ECG) sampling of R-R interval variation is
regulated by the net effect of sympathetic and parasympa-
thetic input. Comprehensive and functional analysis of
heart rate variability (HRV) has served as a reliable nonin-
vasive technique for quantitative assessment of cardiovas-
cular autonomic regulatory responses, providing a dynamic
map of sympathetic and parasympathetic interaction [9].
Clinical studies have consistently shown reduced HRV in
people with work stress [10] or psychosomatic symptoms
such as depression [11], anxiety [12], and chronic fatigue
syndrome [13]. A series of the authors’ previous research
has shown that autonomic function, evaluated by HRV, was
altered among women with psychosomatic problems, in-
cluding premenstrual [14, 15] or menopausal symptoms
[16]. In contrast, individuals with greater emotion-
regulation ability have been shown to have greater levels of
resting HRV [17]. Several studies have investigated clinical
benefits of aromatherapy by using HRV and demonstrated
significant changes of autonomic nervous system activity
after inhalation of essential oils, including lavender [18–21],
jasmine [19] and bergamot [22–24], while affecting mood,
mental conditions and behavior. These findings demon-
strate the functionality of HRV measurements to evaluate
psychophysiological effects of aromatherapy with yuzu fra-
grance from the perspective of autonomic nervous system
activity as it reflects mind and body interaction.
Accordingly, the present study used a single-blind ran-
domized controlled crossover design to measure the ef-
fects of commercially available yuzu essential oil on
mood states and autonomic nervous system activity by
using HRV measurements in the follicular and luteal
phases of eumenorrheic women. A majority of women
experience a regular recurrence of various symptoms in
the premenstrual phase, although the symptom complex
does not always reach clinically significant levels, such as
premenstrual syndrome (PMS) or premenstrual dys-
phoric disorder (PMDD) [25]. This study then investi-
gated if inhalation of yuzu fragrance could serve as an
additional modality to alleviate psychoemotional stress
and if the menstrual cycle influences the efficacy of yuzu
aromatherapy among reproductive-age women.
Methods
Subjects
Twenty one women in their 20s volunteered to participate
in a single-blind randomized controlled crossover study.
The women, all college students, responded to a campus
advertisement. The study protocol was approved in ad-
vance by the Institutional Review Board of Shitennoji
University and was performed in accordance with the
Declaration of Helsinki of the World Medical Association.
All subjects received an explanation of the nature and
purpose of the study: to investigate soothing effects of
plant fragrance on emotional symptoms during the men-
strual cycle. We did not, however, inform subjects of
which fragrance we would use for the experiments. We
mentioned neither the concentration of the fragrance nor
the use of water as a control trial. Prior to receiving any
data about the experiments, all subjects gave their written
informed consent to participate in the study.
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The subjects underwent medical examinations and in-
terviews and completed a standardized health question-
naire regarding medical history, medications, current
health condition, regularity of menstrual cycle, premen-
strual discomfort, and lifestyle. While referring to subjects’
self-reported regular menstrual cycles, we determined the
cycle phase during the experiments by the onset of
menstruation and oral temperature and verified it by the
concentrations of ovarian hormones, estrone (E1), and
pregnanediol-3-glucuronide (PdG), in a urine sample
taken early in the morning. Both E1 and PdG were
indexed to creatinine (Cr) excretion [14, 15, 26].
Menstrual-cycle related discomfort, such as PMS
and PMDD, influences the autonomic nervous system
[14, 15, 26–28]. As in our previous studies [14, 15],
therefore, we asked subjects to answer the menstrual dis-
tress questionnaire [29] in the follicular (the fifth to the
eleventh day from the first day of menstruation) and the
late-luteal phase (within seven days before the next men-
struation) to determine the severity of premenstrual
symptoms. The average value of the increase on the total
scores of the questionnaire from the follicular to the late-
luteal phase was 4.0 ± 2.5 %. None of the women reported
that premenstrual symptoms markedly interfered with
work, school, usual activities or relationships with others.
Considering this information, no subjects in the present
study suffered from PMS or PMDD, but the subjects’
symptoms did fall within the sphere of premenstrual moli-
mina, signalling impending normal menstruation, which a
majority of reproductive-age women experience [25, 30].
None of the subjects had been clinically diagnosed
with diabetes mellitus, hypertension, hyperlipidemia, or
cardiovascular or any other endocrine or systemic disor-
ders that could affect the autonomic nervous system.
The subjects were non-obese and non-smokers. Before
starting the study, none of the women reported taking
oral contraceptives to control the menstrual cycle or any
other medications influencing the autonomic nervous
system.
Referring to human-subject research on olfactory
stimulation from aroma [6, 21, 31], this study performed
the olfactory function test on all subjects to assure that
none had anosmia. Briefly, subjects were given two sets
of three bottles—two held distilled water; the third con-
tained essential oils (yuzu or lavender)—and were asked
to choose the one that differed from the other two. To
be eligible for the study, subjects had to choose the cor-
rect response in both trials.
All subjects were asked not to consume any food
or beverages containing alcohol or caffeine after
21:00 of the day preceding the experiment. The sub-
jects were also instructed to abstain from alcohol
use and excessive physical activity for 24 h before
testing [14, 21].
Experimental procedure
Subjects were examined twice each (aroma and control
trials) in the follicular (the fifth to the eleventh day from
the first day of menstruation) and late-luteal phases
(within seven days before the next menstruation). Con-
sidering subjects’ menstrual cycles and availability to
come to the laboratory for this research project, the
order of testing was randomized. Table 1 summarizes
the randomization of four trials. As the table indicates,
for instance, Subject 1 participated in the trials in the
following order: Late-luteal yuzu, follicular yuzu, late-
luteal water, follicular water trials. Two subjects—S3 and
S5—discontinued the trials due to menstrual irregularity
(extended menstrual duration) and taking a prescribed
medication, during the study, respectively. One subject
(S8) could not manage her schedule to participate in the
remaining three trials after the late-luteal water trial.
Therefore, 18 subjects completed all four trials.
All measurements were taken between 11:00 and
15:00 and were performed in a temperature-controlled
(25 °C), quiet, comfortable room with a minimization
of arousal stimuli. Height and body weight of each
subject were measured to calculate body mass index
(BMI) as body weight divided by height squared.
Table 1 Randomization of four trials
Follicular Late luteal
Subject number Yuzu Water Yuzu Water
S1 2 4 1 3
S2 2 3 1 4
S3 2 1
S4 2 4 1 3
S5 1 2
S6 4 3 2 1
S7 4 1 2 3
S8 1
S9 3 1 2 4
S10 2 3 1 4
S11 3 2 4 1
S12 3 4 1 2
S13 3 4 1 2
S14 2 1 3 4
S15 2 3 1 4
S16 1 4 3 2
S17 3 1 2 4
S18 1 2 3 4
S19 3 4 2 1
S20 1 4 3 2
S21 1 2 3 4
The numbers (1, 2, 3, and 4) indicate the order of trials each subject
participated in
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Subjects then rested for at least 10 min before the
start of the experiment.
This experiment used two kinds of aroma stimulation:
yuzu (Citrus junos Sieb. ex Tanaka, Lot No. 20, TREE
OF LIFE Co., Ltd., Tokyo, Japan) and water as a control.
The major components of the yuzu essential oil used in
this study are as follows: limonene 78.02 %, γ-terpinene
9.32 %, β-myrcene 1.77 %, α-pinene 1.34 %, δ-elemene
0.79 %, β-pinene 0.69 %, β-caryophyllene 0.60 %, α-
phellandrene 0.43 %, terpinolene 0.41 %, p-cymene
0.38 %, α-terpinenol 0.07 %, linalool 0.03 % (unidentified
minor compounds constitute the remaining 6.15 %).
According to previous research on aromatherapy with
floral and citrus fruit essential oil [6, 21], we pipetted
10 μl of yuzu essential oil or water onto a small cotton
pad designed for a diffuser (Aroma breeze NOVA T,
ALTA Corporation, Nagoya, Japan). Airflow from the
diffuser was set at 1.3 m per min and placed near the
subject’s nostrils using the diffuser’s 30-cm long circular
cylinder fitted with a perforated funnel (diameter 5 cm).
Before measurements were taken, the subjects were
instructed to relax quietly and comfortably for at least
10 min in a seated position while equipped with electro-
cardiograph (ECG) electrodes. They then filled out the
Profile of Mood States (POMS) explained in detail
below. The ECG was recorded 5 min before inhalation
of the scent. Each subject then inhaled the scent for
10 min. Right after the aroma stimulation, each subject
rated the scent’s intensity, pleasantness and familiarity,
and her likes and dislikes regarding the scent by using a
visual analogue scale (VAS) with a 10-cm horizontal line
[31]. We again measured the ECG for 5 min at 0, 10, 20,
and 30 min after inhalation. During ECG recording, all
subjects breathed in synchrony to a metronome at 15
beats per minute to ensure that the respiratory-linked
variations in heart rate did not overlap with low-
frequency heart-rate fluctuations (below 0.15 Hz) from
other sources [15, 21]. After the ECG was recorded, the
subjects repeated the POMS test. The ECG signals were
later analysed by means of HRV power spectral analysis,
as described below, to evaluate whether aroma stimula-
tion changed autonomic nervous system activity.
Evaluation of autonomic nervous system activity
The technique of the HRV power spectral analysis for the
present investigation has been applied in basic physio-
logical and clinical research fields, and its validity and reli-
ability have been previously confirmed [15, 21, 32]. We
thus briefly explain the procedure of R-R interval power
spectral analysis used in the present study. The ECG sig-
nal was amplified (MEG-6108, Nihon Kohden, Tokyo,
Japan) and digitized via a 16-bit analog-to-digital con-
verter (Model PS-2032GP, TEAC, Tokyo, Japan) at a
sampling rate of 1000 Hz. The digitized ECG signal was
differentiated, and the resultant QRS spikes and the inter-
vals of the impulses (R-R intervals) were stored sequen-
tially on a hard disk for later analysis.
Before the R-R spectral analysis was performed, the
stored R-R interval data were aligned sequentially to ob-
tain equally spaced samples with an effective sampling
frequency of 2 Hz and displayed on a computer screen
for visual inspection. Then, the direct current compo-
nent and linear trend were completely eliminated by
digital filtering for the band-pass between 0.03 and
0.5 Hz. The root mean square value of the R-R interval
was calculated as representing the average amplitude.
After passing through the Hamming window, power
spectral analysis by means of a fast Fourier transform
was performed on a consecutive 256-s time series of R-R
interval data obtained during the test. Spectral powers
were calculated for the following respective frequency
bands: low frequency (LF) power (0.03–0.15 Hz), an
indicator of both sympathetic and parasympathetic
nervous system activity; high frequency (HF) power
(0.15–0.5 Hz), which solely reflects parasympathetic
nerve activity; and total power (0.03–0.5 Hz) represent-
ing overall autonomic nervous system activity.
Basal heart rates and autonomic nervous system ac-
tivities differ from individual to individual. Thus, the
mean values for heart rates before inhalation of a
scent were set as the baseline values and the mean
values for autonomic nervous system activity before
the inhalation were standardized to 100 %. The rate
of change after the inhalation was compared between
aroma and control trials [19, 21].
Assessment of emotional symptoms
We administered the Japanese version of the POMS test
(Kaneko Shobo Co., Tokyo, Japan), a globally standard-
ized, self-administered, 65-item questionnaire (including
7 dummy items) to assess mood states before and after
inhalation of the yuzu aroma and water. Participants
rated each item in terms of how strongly they had felt it
during the past week, including the current day, on a
five-point Likert-type scale of zero to four, ranging from
“not at all” to “extremely.” We added these raw scores to
generate six subscales of emotional state: tension–anxiety,
depression–dejection, anger–hostility, vigor, fatigue, and
confusion. These added raw scores were then converted
into T-scores according to the POMS manual [33]. As a
global measure of affective state, we also calculated a total
mood disturbance (TMD) score, with higher scores indi-
cating more mood disturbance, by adding the T-scores on
the six subscales, with vigor negatively weighted [6, 21,
34]. It should be noted that the POMS test has been used
to evaluate acute effects of clinical intervention including
aromatherapy [6, 19, 21], since the scores reflect temporal
moods and feelings that can change depending on a
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situation someone is in [33]. Referring to previous aroma
research [6, 19, 21], to investigate the effect of the yuzu
aroma on mood states, we compared changes in the
POMS scores of the yuzu and control trials before and
after the ECG measurements in the follicular and late-
luteal phases.
Statistical analysis
To investigate the influence of inhalation of the yuzu
aroma on autonomic nervous system activity, we evalu-
ated the effects of menstrual cycle, aroma, and time and
their interactions (cycle x aroma, cycle x time, aroma x
time, cycle x aroma x time) using three-way ANOVA
with repeated measures. As to psychoemotional symp-
toms, we performed two-way ANOVA with repeated
measures to evaluate the effects of menstrual-cycle and
aroma and the interactions (cycle x aroma) on scores of
the VAS scale rated right after the aroma inhalation
period and changes in scores of the POMS test before
and 35-min after the aroma inhalation period. Values are
reported mean ± standard errors (SE). P values < 0.05
were considered statistically significant. All statistical
analysis was performed using a commercial software
package (IBM SPSS Statistics Version 22).
Results
Clinical characteristics of subjects
Table 2 represents the mean values of the physical fea-
tures of 18 subjects who completed the aroma and water
control trials in the follicular and late-luteal phases. The
aroma and control experiments took place on the 7.6 ±
0.4th day and the 7.8 ± 0.4th day in the follicular phase
and the 26.8 ± 0.6th day and the 27.6 ± 0.8th day in the
late-luteal phase from the first day of menstruation, re-
spectively. The interval between the two trials was 2.4 ±
0.3 days and 2.1 ± 0.3 days in the follicular and the late-
luteal phases, respectively.
To confirm regular ovulatory menstrual cycles among
subjects, we measured their oral temperatures (MC-
172 L, Omron, Kyoto, Japan) and urinary ovarian hor-
mone concentrations in the follicular phase (7.5 ± 0.5th
day) and in the late-luteal phase (26.0 ± 0.7th day). The
basal body temperature in the late-luteal phase sig-
nificantly increased from that of the follicular phase
(36.54 ± 0.09 vs. 36.26 ± 0.05 °C, P = 0.001). We also
found significant late-luteal increase in urinary ovar-
ian hormones compared to the follicular phase (E1:
20.9 ± 2.5 vs. 10.5 ± 2.0 ng/ml Cr, P < 0.001; PdG: 1.59 ±
0.23 vs. 0.27 ± 0.05 μg/ml Cr, P < 0.001).
Comparisons of acute psychological effects between yuzu
and control trials
Table 3 shows the acute psychological effects evaluated
with VAS right after the 10-min aroma stimulation with
yuzu and water in the follicular and late-luteal phases.
We found no menstrual-cycle effects and the interaction
(cycle x aroma) on any items, but significant aroma ef-
fects on all four items—intensity, likes and dislikes,
pleasantness, and familiarity.
Autonomic nervous system activity before and after
inhaling aromas
Figure 1 represents the case of ECG R-R interval
changes and the corresponding power spectra before,
immediately after, and 30 min after the 10-min aroma
inhalation by a 22-year-old subject. In the follicular
phase, the HF power representing the parasympathetic
nervous system activity markedly increased right after
the inhalation period with the yuzu fragrance. At 30 min
after the inhalation period, the HF power slightly de-
creased but remained higher compared to the baseline.
In the late-luteal phase, the HF power also apparently
increased immediately after the inhalation period with
the fragrance of yuzu and further increased at 30 min
after the aroma inhalation period. Regardless of men-
strual cycles, in contrast, the HF power did not change
during the control trials with water.
Figure 2 shows the changes of heart rates after the
aroma stimulations. We found no significant effects of
menstrual cycle and the related interactions (cycle x
aroma, cycle x time, cycle x aroma x time) on the
change of heart rates. As the figure represents, heart
rates more significantly decreased after the aroma stimu-
lations with yuzu compared to water [aroma effect:
F(1,16) = 4.70, P = 0.046; time effect: F(4,64) = 21.61, P <
0.0001; aroma x time effect: F(4,64) = 4.14, P = 0.005].
Further statistical analysis with paired t test revealed that
heart rate more significantly decreased at 20–25 min in
the follicular phase (P = 0.011) and at 10–15 min in the
late-luteal phase (P = 0.045) after the 10- min inhalation
of yuzu fragrance compared to water.
Figure 3 graphs the time course of the changes of HF
power for 35 min after the aroma stimulations. After in-
haling the yuzu aroma, the rate of increase in HF power
seemed greater in the follicular phase. As with the
change of heart rates, however, we found no effects of
menstrual-cycle and the related interactions (cycle x
aroma, cycle x time, cycle x aroma x time) on the
Table 2 Physical features of subjects (n = 18)
Age (years) 20.8 ± 0.2
Height (cm) 160.1 ± 1.4
Weight (kg) 52.8 ± 1.3
Body Mass Index (kg/m2) 20.6 ± 0.4
Menstrual cycle (days) 30.4 ± 0.9
Duration of menstrual flow (days) 6.6 ± 0.3
The values are given as means ± SE
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change of HF power. We observed a significant increase
in the HF power after the inhalation period of the yuzu
scent in comparison with inhalation of the water [aroma
effect: F(1,16) = 12.37, P = 0.003; time effect: F(4,64) =
9.43, P < 0.0001; aroma x time effect: F(4,64) = 5.79, P <
0.0001]. Paired t test further clarified that the rate of in-
crease of HF power was greater at 0–5 min (P = 0.03)
and 20–25 min (P = 0.008) in the yuzu trial compared to
the control trial with water in the follicular phase. In the
late-luteal phase, HF power increased more significantly
Table 3 Comparison of acute psychological effects evaluated with the visual analogue scales right after the inhalation of yuzu or
water
Follicular Late luteal
Yuzu Water Yuzu Water ANOVA
Intensity 6.1 ± 0.5 0.5 ± 0.3 6.5 ± 0.5 0.7 ± 0.3 Cycle effect: F(1,17) = 1.84, P = 0.19
Aroma effect: F(1,17) = 118.30, P = <0.001*
Interaction: F(1,17) = 0.15, P = 0.71
Likes and dislikes 8.1 ± 0.4 4.8 ± 0.3 8.5 ± 0.4 4.5 ± 0.3 Cycle effect: F(1,17) = 0.035, P = 0.85
Aroma effect: F(1,17) = 67.37, P = <0.001*
Interaction: F(1,17) = 2.68, P = 0.12
Pleasantness 7.5 ± 0.3 4.5 ± 0.4 7.6 ± 0.3 4.7 ± 0.3 Cycle effect: F(1,17) = 0.29, P = 0.60
Aroma effect: F(1,17) = 44.93, P = <0.001*
Interaction: F(1,17) = <0.001, P = 0.99
Familiarity 8.1 ± 0.3 4.8 ± 0.4 8.1 ± 0.3 4.9 ± 0.6 Cycle effect: F(1,17) = 0.012, P = 0.91
Aroma effect: F(1,17) = 68.39, P = <0.001*
Interaction: F(1,17) = 0.049, P = 0.83
The values are given as means ± SE; *Statistical significance
Fig. 1 ECG R-R interval changes and corresponding power spectra before, immediately after, and 30 min after the 10-min inhalation of yuzu
fragrance and water in the follicular and late-luteal phases by a 22-year-old subject. LF: low frequency power (0.03–0.15 Hz); HF: high frequency
power (0.15–0.5 Hz)
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at 10–15 min (P = 0.032) and 20–25 min (P = 0.005) in
the yuzu trial than in the control trial with water. We
also calculated the ratio of LF power to HF power indi-
cating sympathovagal balance. As suggested previously
[7, 8], however, no statistically significant difference was
detected in the relative values between the two trials or
the two menstrual phases.
Changes of mood states 30 min after the inhalation
period with yuzu fragrance
We found no significant menstrual-cycle effects and the
interaction (cycle x aroma) on the TMD scores of the
POMS test after the 10-min aroma stimulations. The stat-
istical procedure, however, revealed significant aroma ef-
fects on the TMD [aroma effect F(1,17) = 5.86, P = 0.027]:
The scores significantly decreased in the yuzu trials
(follicular phase −8.4 ± 3.4, late-luteal phase −8.2 ± 3.2)
compared to the control trial with water (follicular
phase −1.8 ± 2.6, late-luteal phase 0.6 ± 1.4).
Figure 4 illustrates the changes of the POMS sub-
scales 30 min after the 10-min aroma inhalation
period. As with the TMD scores, we found no signifi-
cant menstrual-cycle effects and the interaction (cycle
x aroma) on the six subscales of the POMS test. As
to the aroma effect, in contrast, the subscores of ten-
sion–anxiety [aroma effect F(1,17) = 7.53, P = 0.014]
and fatigue [aroma effect F(1,17) = 5.60, P = 0.030] sig-
nificantly decreased after the inhalation of yuzu as
compared to those of the control trial with water.
Other negative symptoms—anger–hostility and confu-
sion—also decreased more in the yuzu trial in both
menstrual cycles, but the changes of the subscores




















Baseline 0-5 min 10-15 min 20-25 min 30-35 min
Yuzu
Water
cycle effect     NS
aroma effect   P=0.046
time effect      P<0.001




















Fig. 2 Changes of heart rates before (baseline) and after (0–35 min) the 10-min inhalation of yuzu fragrance and water in the follicular and late-
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Fig. 3 Rate of increase of high frequency (HF) power before (baseline) and after (0–35 min) the 10-min inhalation of yuzu fragrance and water. A
significant difference by paired t test was apparent between yuzu and control (water) trials (** P < 0.01, * P < 0.05)
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Discussion
Yuzu, originally found in the upper reaches of the
Yangtze River in China, arrived in Japan during the Sui
Dynasty or Tang Dynasty over 1000 years ago [5]. The
citrus fruits have been widely cultivated in Japan and
have many uses, from cuisine and food products to
health-promoting items. Yuzu has attracted worldwide
attention: a 2003 article in the New York Times pro-
claimed yuzu the darling of chefs and as having an
amazing floral citrus aroma [35]. The question emerges,
as a matter of course, how and why does the yuzu aroma
produce psychodynamic effects? To what extent does the
autonomic nervous system, which plays a critical part in
the integrity of the mind-body connection as the func-
tional driver of general health and wellness, contribute to
efficacious outcomes brought about by the fragrance?
The present study investigated the soothing effects of
olfactory stimulation by the yuzu fragrance on auto-
nomic nervous system function using HRV power
spectral analysis in conjunction with psychoemotional
symptoms among reproductive-age women. The study
also explored the influence of menstrual phases on the
aromatic effects of yuzu. The main findings reveal that
only a 10-min inhalation of the yuzu scent significantly
decreased heart rate and increased HF power of HRV
reflecting parasympathetic nervous system activity, re-
gardless of menstrual phases. This significant physio-
logical effect continued for at least 25 min. POMS
tests, in addition, demonstrated that inhalation of the
aromatic yuzu oil significantly decreased TMD, a glo-
bal measure of affective state, together with two
POMS subscales—tension-anxiety and fatigue, as long
as 35 min after the aroma stimulation, both in the
follicular and late-luteal phases.
While we mentioned the paucity of information on the
effects of yuzu inhalation, Kumagai et al. [36] reported
their findings from an animal study in a Japanese aroma
research journal: olfactory stimulation by the yuzu scent
decreased activities of sympathetic nerves innervating
brown adipose tissue and white adipose tissue in
urethane-anesthetized rat. We found two other articles
[7, 8] investigating the efficacy of yuzu aroma on human
subjects, which were also published in Japanese scientific
journals. A clinical study by Sawamura and colleagues
[7] revealed that after inhaling yuzu fragrance (n = 24),
an inpatient group fell asleep more easily on the night
before an operation and woke up feeling better as com-
pared to the control group (n = 26). These researchers
also conducted an experiment to evaluate the physio-
logical effects of one-minute olfactory stimulation from
the yuzu fragrance by using ECG among healthy individ-
uals (n = 13, 20–56 years [the sex ratio was not re-
ported]). The results showed that heart rate significantly
decreased after inhalation of yuzu aroma compared to
the control trial with no fragrance. The coefficient of
variation of R-R intervals, an index of parasympathetic
nervous system activity, was greater in the yuzu trial
than in the control trial, but the difference between the
two trials was not statistically significant. According to
Konno [8], who examined subjects with subclinical de-
pression (male n = 4, female n = 4, 22.3 ± 2.8 years), a 7-
min inhalation of yuzu fragrance significantly decreased
two subscores of the short version of POMS—anger–
hostility and fatigue—and increased the subscore of
Fig. 4 Subscore changes in the Profile of Mood States (POMS) test performed before and 35 min after the 10-min inhalation of yuzu fragrance
and water. A significant difference was apparent between yuzu and control (water) trials (* P < 0.05)
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vigor. As to physiological measurements using acceler-
ation plethysmography, the ratio of LF to HF power de-
creased, and the coefficient of the variation of the a-a
intervals, indicating parasympathetic nervous system ac-
tivity, increased, although the changes did not reach stat-
istical significance.
Based on a literature survey using the PubMed data-
base, as of March 1, 2016, the authors found 33 articles
when using the keyword yuzu for the search. Only two
articles, however, addressed human-subject studies to
evaluate the soothing effects of yuzu aroma [6, 37]. From
the psychological point of view, a clinical study with 121
participants (aromatherapy group n = 61, control group
n = 60) conducted by Ueki et al. [37] showed that aroma-
therapy with yuzu fragrance significantly ameliorated the
anxiety of mothers of sick children undergoing an infu-
sion at a pediatric clinic. This study did not measure any
physiological data including HRV measurements. The
other article with a randomized controlled crossover
study [6] demonstrated that 10-min inhalation of yuzu
scent significantly decreased salivary chromogranin
A—an endocrinological stress marker reflecting sympa-
thetic nervous system activity—among healthy women
(n = 20, 20.5 ± 0.1 year) in the follicular phase. In
addition, the subscores of tension-anxiety, depression-
dejection, anger-hostility, and confusion, as well as
TMD, of the POMS test significantly decreased after the
olfactory stimulation of the yuzu fragrance.
As to the psychological evaluation of yuzu aroma, the
present study, as well as the earlier human studies men-
tioned above [6, 8], used the POMS test. All three inves-
tigations revealed that even a short-term inhalation of
the yuzu fragrance decreased the POMS score of nega-
tive symptoms, indicating a healthcare intervention with
yuzu aroma could improve emotional mood states. The
results were, however, not always consistent among the
studies. The differences in experimental designs and
conditions, intensity of olfactory stimulation with yuzu
aroma and clinical features of subjects might lead to the
inconsistencies among the outcomes of the psychological
measures.
When essential oils are inhaled, the individual volatile
molecules are carried by eddy currents to the roof of the
nose, where delicate cilia protrude from the receptor
cells into the nose itself. When the molecules lock on to
these hairs, an electrochemical message is transmitted
via the olfactory bulb and olfactory tract to the primary
olfactory regions in the brain, and most of the brain re-
gions strongly relate to, or make up, part of the limbic
system, the center of autonomic function and emotion
[3]. The HRV power spectral analysis used in the present
study serves as a valuable noninvasive device to evaluate
sympathovagal activity. However, we should state that
the device has a disadvantage: it cannot single out
sympathetic nervous system activity, although some
studies have referred to absolute or relative values of LF
power or the LF to HF ratio as an alternative index of
sympathetic nervous function [18, 22]. At the moment,
we cannot fully elucidate the detailed mechanism of
yuzu’s efficacy. However, the significant increase in HF
power after the inhalation of yuzu found in the present
study additionally suggests that yuzu interacts, at least in
part, with the autonomic nervous system to increase para-
sympathetic nerve activity, which consequently modulates
the cluster of negative psychoemotional symptoms.
To further explore the potential efficacy of the yuzu
fragrance, the authors reviewed the literature on sci-
entific research analyzing psychophysiological and be-
havioral effects of other citrus fruit essential oils.
Both animal and human studies demonstrated that
fragrance inhalation of essential oil from grapefruit
(Citrus paradisi) increased sympathetic nervous system
activity [38–40]. Limonene, accounting for approximately
95 % of the volatile components of grapefruit, contributes
to sympathetic stimulatory effects and subjective alertness
[38, 39]. Interestingly, other citrus fruits consisting of less
limonene have the opposite effect of grapefruit on
autonomic function. Female patients who were exposed to
ambient fragrance from sweet orange (Citrus sinensis) peel
oil, made up of limonene (88.1 %), myrcene (3.77 %), and
α-pinene (1.19 %), showed a lower level of anxiety, a more
positive mood, and a higher level of calmness in a dental
office setting [41]. Three studies [22–24] evaluated the
efficacies of bergamot essential oil (Citrus bergamia) by
using HRV power spectral analysis and demonstrated that
short-term inhalation of the fragrance generated from a
diffuser significantly increased HF power. The results of
the LF to HF ratios were inconsistent among the three
studies. An investigation by Watanabe et al. [24] used ber-
gamot essential oil, consisting of limonene (45.45 %), lina-
lyl acetate (23.10 %), γ-terpinene (8.05 %), β-pinene
(7.25 %), linalool (6.50 %), and α-pinene (1.35 %) and fur-
ther clarified that salivary cortisol levels together with
negative emotions, including anxiety, significantly de-
creased after inhaling bergamot fragrance. As we men-
tioned in Method, limonene is a major component
(78.02 %) of the yuzu essential oil presently used, but the
yuzu essential oil contains less limonene than the grape-
fruit essential oil. The second major component of yuzu,
γ-terpinene (9.32 %), promotes dopamine release, result-
ing in stress reduction [42]. Yuzu shares other common
components with lavender, a representative of relaxing es-
sential oils, such as β-caryophyllene and linalool, which
also have sedative effects [19, 21]. Yuzu, as well as sweet
orange and bergamot, contains α-pinene—a major phy-
toncide, and has calming effects on autonomic stress re-
sponse to novel environments [43]. A combination of
limonene with these volatile components might augment
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parasympathetic nervous system activity to modulate the
psychoemotional status. However, revealing the psycho-
logical, neurophysiological, and pharmacological functions
of yuzu essential oil will require further interdisciplinary
scrutiny and research.
The present study demonstrated no significant difference
in the psychophysiological effects of the yuzu aroma during
the menstrual cycle. The authors suggest caution in inter-
preting the findings since the data of the present study were
obtained at two different time points, the follicular and the
late-luteal phases. The influence of the menstrual cycle on
olfactory sensitivity has been studied for over 50 years, but
continues to be a matter of debate. For instance, according
to a study by Doty et al. [44], peaks in olfactory sensitivity
to the odor of furfural, a colorless liquid with a distinctive
smell, were observed mid-cycle, mid-luteally, and during
the second half of menses in women both taking and not
taking oral contraceptives. In contrast, some investigators
reported no menstrual cycle-related fluctuations in
sensitivity to phenyl ethanol, androstenone, nicotine,
and citral [45, 46]. Previous practical or clinical research
revealed that aromatherapy alleviates menstrual-related
problems, such as dysmenorrhea [47] and PMS [21, 48].
At the time of writing, however, no studies have examined
whether the soothing effects of olfactory stimulation from
fragrances or the efficacy of aromatherapy change during
the menstrual cycle. To scrutinize the influence of the
menstrual cycle on yuzu’s aromatic effects, future studies
should be designed to measure a broader range of psycho-
neuroendocrinological parameters, including gonadal hor-
mones and basal body temperature in addition to the
autonomic functions and psychometric tools presently
used, and to investigate them more frequently, i.e., men-
strual, follicular, ovulatory, and early- and late-luteal
phases, during a menstrual cycle among eumenorrheic
women without oral contraceptives (OCs) and women
with OCs as a control group. The authors’ previous stud-
ies demonstrated that the HF power of HRV at rest de-
creased in the late-luteal phase among women suffering
from PMS, but women with no or slight premenstrual
symptoms, categorized as premenstrual molimina, showed
no menstrual cyclicity of autonomic nervous system activ-
ity [14, 15]. From the clinical point of view, therefore, we
need to further investigate if the therapeutic efficacy of
yuzu differs among women with different degrees of
menstrual-related symptoms.
Several limitations of the present study deserve mention.
First, the present study used two kinds of aromas, yuzu
and water as a control. To avoid placebo effects, we did
not inform subjects of which fragrance we would use for
the experiments. We mentioned neither the concentration
of the fragrance nor the use of water as a control trial. We
cannot, however, completely deny the possibility that the
participants would have noticed the difference when they
inhaled the aroma of water. Second, as Table 3 shows, par-
ticipants in this study evaluated the yuzu fragrance as
pleasant. This study, however, employed a relatively small
sample size. We thus need to explore the physiological re-
sponse to the inhalation of yuzu essential oil among a lar-
ger sampling of women who consider the fragrance
pleasant or unpleasant and compare the results between
the two groups. To better explore the net psychological
and pharmacological effects of the yuzu fragrance, it
would be of interest to investigate experimental conditions
with four olfactory stimuli—unscented water, the yuzu
scent, and other kinds of scents considered both pleasant
and unpleasant by participants. Finally, to scrutinize the
efficacy of the yuzu aroma, further studies should be con-
ducted to examine if the yuzu fragrance has gender-
dependent effects on improving psychoemotional states.
In addition, other factors, such as age and ethnicity, may
influence olfactory and psychoneuroendocrinologic sys-
tems in humans.
Conclusions
In conclusion, the present study, using HRV power spec-
tral analysis, demonstrated that short-term inhalation of
fragrance from yuzu essential oil significantly decreased
heart rate and increased the HF power of HRV, regard-
less of menstrual phases. Although the underlying mech-
anisms of the soothing effects of yuzu remain unclear,
this study indicates that yuzu’s aromatic effects could al-
leviate negative emotional stress, which, at least in part,
contributes to the improvement of parasympathetic ner-
vous system activity.
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